Skip to main content

Table 1 Metabolic syndrome defined by the modified WHO, IDF, ATP III, and JIS diagnostic criteria

From: The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: Two decades of follow-up from the Tehran Lipid and Glucose Study

The modified WHO definition [29]

The IDF definition

[30]

The ATP III definition

[31]

The JIS definition

[32]

DM or IGT [2 h-PG ≥ 140 mg/dl (7.8 mmol/l)] Plus two or more of the following:

WC ≥ 95 cm Plus any two or more of the following:

Three or more of the following:

Three or more of the following:

–

FPG ≥ 100 mg/dl

(5.6 mmol/l) or drug treatment

FPG ≥ 110 mg/dl (6.1

mmol/l)

FPG ≥ 100 mg/dl

(5.6 mmol/l) or drug treatment

TG ≥ 150 mg/dl (1.7 mmol/l)

or

M: HDL-C < 35 mg/dl

(0.9 mmol/l)

F: HDL-C < 39 mg/dl

(1.0 mmol/l)

TG ≥ 150 mg/dl (1.7 mmol/l)

or drug treatment

TG ≥ 150 mg/dl

(1.7 mmol/l)

TG ≥ 150 mg/dl (1.7 mmol/l) or drug treatment

M: HDL-C < 40 mg/dl

(1.03 mmol/l)

F: HDL-C < 50 mg/dl

(1.29 mmol/l)

or drug treatment

M: HDL-C < 40 mg/dl

(1.03 mmol/l)

F: HDL-C < 50 mg/dl

(1.29 mmol/l)

M: HDL-C < 40 mg/dl

(1.03 mmol/l)

F: HDL-C < 50 mg/dl

(1.29 mmol/l)

or drug treatment

BMI > 30 kg/m2

or

M: WHR > 0.90

F: WHR > 0.85

-

M: WC > 102 cm

F: WC > 88 cm

WC ≥ 95 cm

BP ≥ 140/90 mmHg or drug treatment

BP ≥ 130/85 mmHg or drug treatment

BP ≥ 130/85 mmHg

BP ≥ 130/85 mmHg or drug treatment

  1. JIS Joint Interim Statement, IDF International Diabetes Federation, ATP III Adult Treatment Panel III, WHO World Health Organization, FPG fasting plasma glucose, DM diabetes mellitus, IGT impaired glucose tolerance, 2 h-PG 2-h post-challenge glucose, WHR waist to hip ratio, WC waist circumference, BMI body mass index, TG triglycerides, HDL-C high-density lipoprotein cholesterol, BP blood pressure, M male, F female